Results	O

The	O
set	O
of	O
E	O
.	O
coli	O
expression	O
vectors	O
,	O
encode	O
for	O
either	O
a	O
hexa	O
-	O
histidine	O
tag	O
or	O
the	O
three	O
most	O
commonly	O
used	O
solubility	O
tags	O
(	O
GST	O
,	O
MBP	O
,	O
NusA	O
)	O
and	O
all	O
with	O
an	O
N	O
-	O
terminal	O
hexa	O
-	O
histidine	O
sequence	O
.	O

The	O
result	O
is	O
two	O
-	O
fold	O
:	O
the	O
His	O
-	O
tag	O
facilitates	O
purification	O
by	O
immobilised	O
metal	O
affinity	O
chromatography	O
,	O
whilst	O
the	O
fusion	O
domains	O
act	O
primarily	O
as	O
solubility	O
aids	O
during	O
expression	O
,	O
in	O
addition	O
to	O
providing	O
an	O
optional	O
purification	O
step	O
.	O

We	O
have	O
also	O
incorporated	O
a	O
TEV	O
recognition	O
sequence	O
following	O
the	O
solubility	O
tag	O
domain	O
,	O
which	O
allows	O
for	O
highly	O
specific	O
cleavage	O
(	O
using	O
TEV	O
protease	O
)	O
of	O
the	O
fusion	O
protein	O
to	O
yield	O
native	O
protein	O
.	O

These	O
vectors	O
are	O
also	O
designed	O
for	O
ligation	O
-	O
independent	O
cloning	O
and	O
they	O
possess	O
a	O
high	O
-	O
level	O
expressing	O
T7	O
promoter	O
,	O
which	O
is	O
suitable	O
for	O
auto	O
-	O
induction	O
.	O

To	O
validate	O
our	O
vector	O
system	O
,	O
we	O
have	O
cloned	O
four	O
different	O
genes	O
and	O
also	O
one	O
gene	O
into	O
all	O
four	O
vectors	O
and	O
used	O
small	O
-	O
scale	O
expression	O
and	O
purification	O
techniques	O
.	O

We	O
demonstrate	O
that	O
the	O
vectors	O
are	O
capable	O
of	O
high	O
levels	O
of	O
expression	O
and	O
that	O
efficient	O
screening	O
of	O
new	O
proteins	O
can	O
be	O
readily	O
achieved	O
at	O
the	O
laboratory	O
level	O
.	O

